pdufa.bio
HomeDecisions › SPRY 2026-05-15

SPRY FDA decision — May 15, 2026

✓ APPROVED

ARS Pharmaceuticals Inc. — Neffy 1 mg (epinephrine nasal spray) · Anaphylaxis.

Run-up into the decision (T-120 → T+5)

PDUFA 5/15/26$13.06$6.7311/28/25
Daily close, T-120 (11/28/25) through T+5. Run-up high $13.06 on 1/14/26, low $6.73 on 11/28/25 (T-120 to T-1). FDA decision 5/15/26. Historical price action, not a forecast.

Key facts

FDA decision date2026-05-15
OutcomeApproved
Drug / candidateNeffy 1 mg (epinephrine nasal spray)
CompanyARS Pharmaceuticals Inc.
120-day run-up (T-120→T-1)+18.0%